Clean Power Hydrogen plc, CPH2, has been admitted to the London Stock Exchange AIM market on 16 February 2022. CPH2 CEO Mr Jon Duffy CPH2 said “Today’s listing and over-subscribed placing, delivered in difficult stock market conditions, is an important milestone for CPH2 and will assist the rapid growth of the Group. The funds raised will further strengthen the Group’s financial position and will enable CPH2 to build out our Doncaster manufacturing operation. CPH2 has an opportunity to penetrate an extremely fast-growing hydrogen market and aims to become a globally recognised, highly profitable designer, manufacturer, and licensor of its Membrane-Free Technology, targeting 4GW production capacity by 2030, an opportunity further advanced by the move onto the public markets.”This move now positions the Group to continue significant investment into its research and development capacity and enhance the intellectual property position whilst establishing a stock of completed units to deliver the substantial and continually growing opportunity pipeline.CPH2 is the holding company of Clean Power Hydrogen Group Limited which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. In addition to a contracted orderbook of 4MW for delivery in 2022, the Group has an established pipeline of new opportunities at varying stages of development, including active discussions with current and quoted customers in respect of potential orders in excess of 160MW. The Group designs and manufactures hydrogen production units that incorporate its MFE technology which, in combination with cryogenic gas separation, delivers hydrogen and oxygen in separate streams. When the Group's MFE is supplied by renewable electricity it delivers green hydrogen with a purity of up to 99.999% and medical grade oxygen.
Clean Power Hydrogen plc, CPH2, has been admitted to the London Stock Exchange AIM market on 16 February 2022. CPH2 CEO Mr Jon Duffy CPH2 said “Today’s listing and over-subscribed placing, delivered in difficult stock market conditions, is an important milestone for CPH2 and will assist the rapid growth of the Group. The funds raised will further strengthen the Group’s financial position and will enable CPH2 to build out our Doncaster manufacturing operation. CPH2 has an opportunity to penetrate an extremely fast-growing hydrogen market and aims to become a globally recognised, highly profitable designer, manufacturer, and licensor of its Membrane-Free Technology, targeting 4GW production capacity by 2030, an opportunity further advanced by the move onto the public markets.”This move now positions the Group to continue significant investment into its research and development capacity and enhance the intellectual property position whilst establishing a stock of completed units to deliver the substantial and continually growing opportunity pipeline.CPH2 is the holding company of Clean Power Hydrogen Group Limited which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. In addition to a contracted orderbook of 4MW for delivery in 2022, the Group has an established pipeline of new opportunities at varying stages of development, including active discussions with current and quoted customers in respect of potential orders in excess of 160MW. The Group designs and manufactures hydrogen production units that incorporate its MFE technology which, in combination with cryogenic gas separation, delivers hydrogen and oxygen in separate streams. When the Group's MFE is supplied by renewable electricity it delivers green hydrogen with a purity of up to 99.999% and medical grade oxygen.
